"No swift action" on US CBD regulation after FDA comments, warns analyst

Home › "No swift action" on US CBD regulation after FDA comments, warns analyst

CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.

20.04	App to cut EU border queues won't be ready in time
19.04	PPG Board of Directors Announce Quarterly Dividend of 65 Cents Per Share
19.04	Can AI help solve Japans labour shortages?
19.04	PPG Board of Directors Authorizes $2.5 Billion Share Repurchase Program
19.04	Warning jailed bankers ruling could hit loan rate
19.04	NFU Statement on EPA E15 Announcement
19.04	Mark Andy hosts successful Digital Symposium
19.04	K-State Animal Sciences and Industry students earn national title for fourth consecutive year
More »

je.st